-
Covaxin to get WHO approval at the earliest
According to WHO, EUL is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.
-
Chinese vaccine makers sign COVAX agreements
Gavi, the vaccine partnership playing a leading role in COVAX, said that it would buy 110 million doses from Sinopharm and Sinovac between now and Oct
-
Positivity rate below 5% for 14 days; experts say end far
The WHO recommends that test positivity should remain at 5% or lower for 14 days before countries or regions reopen
-
WHO warns delta variant taking hold in Europe
WHO's Dr Hans Kluge said the variant also known as the delta variant, has shown signs of being able to evade some vaccines
-
Brazil clears import of Bharat Biotech’s Covaxin, Russia’s Sputnik V
According to Brazillian health regulator Anvisa, Brazil is expected to receive four million doses of Covaxin initially.
-
US, India, China account for 60% of 2 billion Covid-19 vaccine doses distributed globally: WHO
While COVAX has played an important role in distributing the Covid-19 doses to 127 countries and getting several countries to start their vaccination
-
Vaccinating children against Covid not priority from WHO perspective: Expert
Children are not typically at risk of getting severely ill or dying from Covid-19, vaccinating them is mostly aimed at stopping transmission, rather t
-
Covid-19: Only one of the three strains is a ‘variant of concern’: WHO
The B.1.617 variant was first detected in India and was divided into three lineages - B.1.617.1, B.1.617.2, and B.1.617.3.
-
WHO names Covid-19 variants found in India ‘Delta’ and ‘Kappa’
The so-called Indian variant B.1.617 is split into sub-lineages, of which the B.1.617.2 variant of concern becomes Delta. The B.1.617.1 variant of int
-
Pfizer tells Centre its Covid-19 vaccine suitable for all aged 12 and above
Pfizer has urged the Indian government to rely upon WHO's testing pathways of reliance on testing certificates from country of origin instead of manda
